drugset / Trial / NCT00141128

Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.

NCT00141128

Phase 2 Completed 18 enrolled Pfizer
RandomizedCrossoverDouble-blindTreatment

Summary

SS-RBX will be used to evaluate pharmacodynamic changes in urethral function using a novel methodology

Timeline

Start
2005-12
Primary completion
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject [S,S]-Reboxetine Unknown 4 mg